News & Analysis as of

Private Equity Firms EBITDA Investors

Holland & Knight LLP

Key Considerations for Independent Sponsors Regarding Portfolio Company Governance

Holland & Knight LLP on

Holland & Knight's Independent Sponsors Team has seen an increasing number of independent sponsors taking part in transactions of seemingly all shapes and sizes. With increasing variation of transactions comes increasing...more

Woodruff Sawyer

Managing Transactional Risk in 2024: A Strategy Guide

Woodruff Sawyer on

As we move further into 2024, we have a clearer perspective on where 2023 ended in the private equity and mergers and acquisitions (M&A) market. We predict more of the same throughout 2024, but there are bright signs for...more

Woodruff Sawyer

Looking Ahead to 2023: Trends in Private Equity and M&A Insurance

Woodruff Sawyer on

When we look across our client base of 375+ funds and our advisory work on 150+ middle market growth equity, private equity, and strategic M&A US-based transactions in 2022, we see a wide variety of issues that are...more

Akin Gump Strauss Hauer & Feld LLP

The Key Dynamics of Private Debt

Executive summary • Despite the COVID-19 pandemic, 2020 still saw robust private equity (PE) activity relative to historical activity, with well over 5,000 completed transactions even amid a drop in aggregate deal value...more

Akin Gump Strauss Hauer & Feld LLP

Unpacking the Dynamics of the Private Debt Market

• Following the financial crisis, nonbank lenders looking to carve out new, profitable niches—especially within the leveraged loan universe—quickly filled the lending gap created by the exit of banks. • The relatively...more

BakerHostetler

PE Investment in Physician Practice Management – What's to Come in 2019?

BakerHostetler on

Private equity (PE) investors entered the physician practice management (PPM) market in 2011, and eight years later the PPM sector continues to be a ripe middle market for PE investors looking to diversify their portfolios. ...more

Foley & Lardner LLP

2018 Private Equity Industry Overview

Foley & Lardner LLP on

Private equity firms entered 2018 amid a confusing mix of record inflows and elevated prices. At the same time, new regulation was expected to raise the cost of capital while also reducing taxes, rolling back limits on...more

McGuireWoods LLP

Leading Private Equity Firms That Invest in Healthcare (Part V)

McGuireWoods LLP on

In 2016, we published a four-part series highlighting some of the more active private equity investors in the healthcare and life science space. Throughout 2017, we continued to see even more PE investors turn toward...more

8 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide